# Taro Pharmaceutical Industries, Ltd., Haifa, Israel – FDA Inspections

Source: https://www.keypedia.com/companies/taro-pharmaceutical-industries-ltd/75bff305-a575-43eb-9c35-401fed5479be

> Inspection records and compliance data for Taro Pharmaceutical Industries, Ltd. in Haifa. 7 FDA inspections on record, 2 Form 483s, last inspected December 08, 2022.

---

## Details

- Name: Taro Pharmaceutical Industries, Ltd.
- FEI Number: 3002808385
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK
- Address Line 1: Haifa Bay, 14, Ha-Kitor
- City: Haifa
- Country Name: Israel
- Address: Haifa Bay, 14, Ha-Kitor, Haifa, Israel
- Country: Israel

## Related Documents

- FDA Inspection 1194198 - Taro Pharmaceutical Industries, Ltd. - 2022-12-08 — classification: No Action Indicated (NAI), source: FDA, date: December 8, 2022
- [483 - Taro Pharmaceutical Industries, Ltd. - 2019-07-11](https://www.keypedia.com/records/483/taro-pharmaceutical-industries-ltd/44cf6f3a-f2c6-40a3-9ff7-7b622a9d7d8b) — source: FDA, date: July 11, 2019
- [FDA Inspection 1097014 - Taro Pharmaceutical Industries, Ltd. - 2019-07-11](https://www.keypedia.com/records/fda_inspections/taro-pharmaceutical-industries-ltd/411c1013-6db4-4217-92a5-2e12bb068bd3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 11, 2019
- [FDA Inspection 1005657 - Taro Pharmaceutical Industries, Ltd. - 2017-02-05](https://www.keypedia.com/records/fda_inspections/taro-pharmaceutical-industries-ltd/90389310-5a59-4dac-a6ed-d10a8a4812d9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 5, 2017
- [FDA Inspection 931084 - Taro Pharmaceutical Industries, Ltd. - 2015-05-21](https://www.keypedia.com/records/fda_inspections/taro-pharmaceutical-industries-ltd/48b5bf13-3a34-4537-995f-b45642ad43a0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 21, 2015
- FDA Inspection 825186 - Taro Pharmaceutical Industries, Ltd. - 2012-12-06 — classification: No Action Indicated (NAI), source: FDA, date: December 6, 2012
- FDA Inspection 671137 - Taro Pharmaceutical Industries, Ltd. - 2010-05-28 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 28, 2010
- FDA Inspection 618029 - Taro Pharmaceutical Industries, Ltd. - 2009-09-10 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 10, 2009

## Related Companies

- [Shandong Anxin Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/shandong-anxin-pharmaceutical-co-ltd/1bbdc465-0634-4e76-994f-a57ad864fc33)
- [Actavis Elizabeth LLC, A Company of Teva](https://www.keypedia.com/companies/actavis-elizabeth-llc-a-company-of-teva/c4a12fda-d6c3-4ad3-bac5-cc2b5695950e)
- [Merck Serono SA](https://www.keypedia.com/companies/merck-serono-sa/11522eec-8d30-492a-90ba-09b167899bdc)
- [Reliance Life Sciences Private Limited](https://www.keypedia.com/companies/reliance-life-sciences-private-limited/14b16d70-e482-4647-a231-4eb4a1aab98f)
- [Genentech, Inc.](https://www.keypedia.com/companies/genentech-inc/709aa262-e8df-42fa-bec6-02673e7f52ec)
- [Boehringer Ingelheim Pharma Gmbh & Co Kg](https://www.keypedia.com/companies/boehringer-ingelheim-pharma-gmbh-co-kg/5b2ffd33-30ee-4e73-bb66-fa96b4549154)
- [F. Hoffmann - La Roche Ltd.](https://www.keypedia.com/companies/f-hoffmann-la-roche-ltd/622e8fa3-95f3-4ed9-a1bd-99dc0748f273)
- [Xellia Pharmaceuticals ApS](https://www.keypedia.com/companies/xellia-pharmaceuticals-aps/5d9704ca-114e-4a65-abca-966a5c4e2a57)
- [Shionogi Pharma Co., Ltd.](https://www.keypedia.com/companies/shionogi-pharma-co-ltd/bb3e5dcd-52f9-4971-9747-4c04b63ba0fa)
- [Aprecia Pharmaceuticals LLC](https://www.keypedia.com/companies/aprecia-pharmaceuticals-llc/126049a3-6c3d-4616-8d44-006827a308c3)

## Related Officers

- [Chemist/Investigator - Pharmaceutical Quality](https://www.keypedia.com/people/walden-h-lee/18131eea-d1cb-47c4-af79-bea22d436031)
- [Yvesna Blaise](https://www.keypedia.com/people/yvesna-blaise/4cd6b7c2-78a7-490d-9354-52046bc7344f)